Comunicati.net - Comunicati pubblicati - pbi Comunicati.net - Comunicati pubblicati - pbi Wed, 20 Jun 2018 11:25:32 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://zend.comunicati.net/utenti/24008/1 Chagas Disease Management Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:48 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/480858.html http://zend.comunicati.net/comunicati/aziende/editoria/480858.html pbi pbi

Chagas Disease Management Market Projected To Grow With Significant CAGR Over The Forecast Period

Global chagas disease management market: Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen lymph nodes, fever, headache, and local swelling at the site of the bite. The chronic symptoms will appear after 8-12 weeks that may include expansion of ventricles leading to heart failure, irregular heartbeat, difficulty in swallowing, and abdominal or colon pain.

 

Rise in the prevalence of Chagas disease due to unhygienic conditions are factors leading to the growth of market. In addition, increase in the R & D of new products are one of the main factors for the market growth. However, lack of awareness regarding the Chagas disease treatment, a limited number of approved products in the current market, and supply chain issues with Chagas disease drugs will hamper the market growth.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-4H8Z4LpNMLEuOnnx

 

The Chagas disease management market is categorized as under-

1.      Type of treatment

·         Anti-parasitic treatment

·         Symptomatic treatment

2.     Drug type

·         Benznidazole

·         Nifurtimox

3.     End-users

Hospital, Online and retail pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-c654SbFYO64MsOhu

 

And lastly, on the basis of geographical regions, the Chagas disease management market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Latin America is the major center for Chagas disease and gradually developing in the rest of world owing to the population mobility from Latin America. Less number of products available in the market for treatment, and poor diagnostic methods to detect in the Latin America region are the major challenges for the Chagas disease management market in this region. North America and Europe are the key regions for Chagas disease management market owing to increase in the prevalence of Chagas disease.

 

Some of the key players in Chagas disease management market are AstraZeneca (U.K), Bayer AG (Germany), Daiichi Sankyo Company Ltd (Japan), Eisai Co Ltd (Japan), GlaxoSmithKline Plc. (U.K), Grupo Praxis Pharmaceutical SA (Spain), Kancera AB (Sweden), Novartis AG (Switzerland), Laboratorio Elea S.A.C.I.F. y A (Argentina), Oblita Therapeutics BVBA (Belgium), and Sanofi Aventis (France) to name a few. In 2017, Daiichi Sankyo Company Limited and Drugs for Neglected Diseases initiative (DNDi) are collaborated to form a joint research with regard to a new research program, the hit-to-lead project to develop the drugs for Chagas disease and Leishmaniasis.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-14mlyhjMGhVjZqa3

 

 

Chagas disease management market is still in the budding stage. Currently, very few players are actively involved in the development of new products for the treatment. Several products are in pipeline that may enter the market near future.  Increase in R & D for new products, acquisitions & mergers, collaborations and providing funds to various organizations can fuel the market growth for Chagas disease. For instance, in 2012, Japan’s Astellas Pharma signed an agreement with the Drugs for Neglected Diseases initiative (DNDi) to collaborate on drug discovery research for three neglected tropical diseases: leishmaniasis, Chagas disease, and sleeping sickness.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Anti-Retroviral Drugs Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:40 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/480857.html http://zend.comunicati.net/comunicati/aziende/editoria/480857.html pbi pbi

Anti-Retroviral Drugs Market Projected To Grow With Significant CAGR Over The Forecast Period

Retroviruses are a single stranded RNA containing virus. Retrovirus use enzyme called reverse transcriptase to copy their RNA into DNA of the host cell. The retrovirus integrates its viral DNA into DNA of the host cell, which allows the retrovirus to replicate. Retroviruses can cause different outcomes for the infected cell.

 

Retroviruses are capable of inducing autoimmune, immunosuppressive, and neurological illnesses. Some retroviruses, such as the spumaviruses and lentiviruses are capable of directly killing cells. Acquired immune deficiency syndrome (AIDS) caused by retrovirus known as Human Immunodeficiency Virus (HIV) and T-Cell leukemia caused by human T lymphotropic virus (HTLV).

 

Antiretroviral drugs are the drugs that acts or inhibit certain process in viral replication and inhibits further worsening of the diseases. Globally antiretroviral drugs market driven by increased cases of retroviral infections such as especially HIV/AIDS. The higher prevalence of HIV owing to the various factors such as lack of availability of medication for the treatment of HIV infection, promising pipeline drugs, increased funding by the government are expected to grow the antiretroviral drugs market. However, high costs of R & D and strict regulatory procedures are hindering the global antiretroviral drugs market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global antiretroviral drugs market is categorized as under- 

1.      Drug class

·         Nucleoside Reverse Transcriptase Inhibitors (NRT’s)

·         Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)

·         Protease Inhibitors

·         Integrate Inhibitors

·         Fusion Inhibitors

·         Chemokine Receptor Inhibitors

·         Others

2.     Route of administration

·         Oral

·         Parenteral

3.     End-users

·         Hospital, retail, online pharmacies and others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

 

And lastly on the basis of geographical regions, the global antiretroviral drugs market is divided into five key regions- North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. North America antiretroviral market is driven by combination drug therapies by key players in this region. Asia Pacific antiretroviral drugs market expected to be fastest growing due to developing healthcare infrastructure and increased awareness by government and non-government organization for retroviral diseases especially HIV/AIDS. The Middle East and Africa region is expected to be key region owing to availability of large pool of patients with retroviral diseases. However, poor healthcare infrastructure and lack of awareness related to retroviral diseases among healthcare professionals expected to hamper market growth in this region.

 

Some of the key players in the global antiretroviral drugs market are Abbott Laboratories (U.S.), AstraZeneca plc (U.K.), Modified Polymer Components, Inc. (Bristol-Myers-Squibb) (U.S), Gilead Sciences (U.S.), GlaxoSmithKline Plc (U.K.), and F. Hoffmann-La Roche AG (Switzerland) to name a few. In 2016, ViiV Healthcare (Pfizer and GlaxoSmithKline’s joint venture) received U.S. FDA approval to market Selzentry for the treatment of CCR5-tropic HIV-1 infection, in combination with other antiretroviral agents.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-14mlyhjMGhVjZqa3

 

Market players are adopting strategies like mergers and acquisitions, collaboration with government and non-government organizations to educate the people and increase awareness related to retroviral diseases. Drugs such as Doravirine (Merck & Co.), Fostemsavir (Bristol-Myers Squibb), etc. are pipeline drugs which are expected to grow the antiretroviral drug market to a significant rate.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Breast Cancer Treatment Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:31 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/480856.html http://zend.comunicati.net/comunicati/aziende/editoria/480856.html pbi pbi

Breast Cancer Treatment Market Projected To Grow With Significant CAGR Over The Forecast Period

Breast cancer is a disease where uncontrolled growth of malignant cells in the breast tissue that is most commonly occurs in female than men. The common signs and symptoms associated with breast cancer include change in the breast shape, lumps in the breast, dimpling of skin, and red scaly patches on the skin. Treatment of breast cancer depends on various factors such as the type of breast cancer, the size of a tumor, stage of breast cancer and the grade of cancer cells. Breast cancer can be treated by various therapies such as radiation therapy, chemotherapy, hormone therapy, targeted therapy and bone-directed therapy.  The breast cancer commonly occurs due to drinking alcohol, being female, obesity, ionizing radiation, genetics and older age, etc. The breast cancer is diagnosed by taking a biopsy of lump. After the diagnosis, further tests are carried to determine the cancer stage and suitable treatment for the disease.

 

The global breast cancer treatment market is expected to increase with significant rate due to increasing breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer treatment market. Furthermore, increased investments in R & D, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology will boost the breast cancer treatment market. However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer treatment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast cancer treatment market is categorized on the basis of - 

1.      Drug class

·         Anthracyclines

·         Antimetabolites

·         Epothilones

·         Taxanes

·         Alkylating agents

·         Hormonal therapy

·         Aromatase inhibitors

·         Selective estrogen-receptor modulators

2.     End-users

·         Hospital, retail and online pharmacies 

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

And lastly on the basis of geographical regions, the global breast cancer drugs market has five major regions- North America, Europe, Latin America, Middle East and Africa and Asia-Pacific. North America dominates the breast cancer treatment market due to increase cases of breast cancer disease, increase in old age female population, and favorable government initiatives for the treatment. Europe holds a major share in breast cancer treatment market owing to rise in the prevalence and incidence of breast cancer cases. Most of the pharmaceutical companies in breast cancer treatment market are focused on R & D, strategic collaborations, acquisitions & mergers, and product launches for the development in the breast cancer treatment market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the key players in breast cancer drugs market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc. (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few. In 2017, U.S. FDA approved the Puma Biotechnology’s Nerlynx (Neratinib) for the treatment of HER2-positive breast cancer in early stage. And in the same year, AstraZeneca received an approval from European Commission (EC) for Faslodex (fulvestrant) for the breast cancer treatment.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Branded Generics Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:22 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/480855.html http://zend.comunicati.net/comunicati/aziende/editoria/480855.html pbi pbi

Branded Generics Market Projected To Grow With Significant CAGR Over The Forecast Period

 

This report studies branded generics market dynamics in emerging markets and developed markets elaborately to identify the current trends, future opportunities, historic market and possible challenges to the key stakeholders operating in the market. In addition, branded generics market report includes new product introductions, regulatory scenario, and competition analysis to analyze the market competition.

 

Branded generics market report deals with detailed market outlook in emerging markets such as Brazil, Russia, China, India, and other Eastern Europe, Latin American countries. Moreover, PBI analyzed branded generics market to better equip clients with possible investment opportunities across the emerging markets. The market for branded generics projected to reach US$ 350.0 billion by 2023. Owing to the widespread prevalence of lifestyle and chronic diseases like diabetes and cardiovascular diseases especially in the emerging market countries, the growth of the branded generics is inevitable.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global branded generics market is categorized as-

1.      Diseases Indication

·         Cardiovascular Diseases

·         Diabetes

·         Cancer

·         Neurological Disorders

·         Gastrointestinal Diseases

·         Dermatology Diseases

·         Others

2.     Route of Administration

·         Oral

·         Parenteral

·         Topical

·         Others

3.     End-users

·         Hospital, retail and online Pharmacies, and drug stores.

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-c654SbFYO64MsOhu

 

 And lastly, on the basis of geographical regions, the global market for branded generics is divided into five regions- North America, Europe, the Middle East & Africa, Latin America and Asia-Pacific.

 

Developed pharmaceutical markets like North America, Europe, and Japan has been witnessing relatively stagnant market growth in comparing with developing markets owing to fewer new product approvals from the regulatory bodies. This has been led to shift the focus by several multinational pharmaceutical companies from matured markets to developing markets to tap unreached and budding market opportunities. 

 

Asia-Pacific accounts for larger market revenue share in global branded generics market. The Asia-pacific region is leading the global Branded Generics market in terms of revenue owing to higher allowance for healthcare expenditure and lack of universal health coverage. Moreover, countries like India, China, and ASEAN countries have better growth opportunities for the existing and new players in the market. Regions such as Asia Latin America and Eastern Europe projected to grow at significant rate. Some of the key market players in the developing market regions are Abbott Laboratories (U.S.), Apotex Inc. (Canada), AstraZeneca (U.K), Reddy’s Laboratories Ltd. (India), GlaxoSmithKline plc (U.K), Mylan N.V. (U.S.), Pfizer Inc. (U.S), Novartis AG (Switzerland), Sanofi (France), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd (Israel), Valeant Pharmaceuticals International, Inc. (Canada).

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-14mlyhjMGhVjZqa3

 

 

Market players are focusing on mergers and acquisitions, strategic alliances, and product diversification to increase the geographic presence in global Branded Generics market. Moreover, players are entering into a distribution agreement with local pharmaceutical companies to overcome the market access barrier in developing regions.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Blood Grouping Reagents Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:10 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/480854.html http://zend.comunicati.net/comunicati/aziende/editoria/480854.html pbi pbi

Blood Grouping Reagents Market Projected To Grow With Significant CAGR Over The Forecast Period

Global blood grouping reagent market: Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks. They are used in determination and identification of antibody type in patient’s and donors’ blood, in order to ensure effective and safe transfusion of blood. Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.

 

Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lack of awareness, paucity of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global blood grouping reagent market is categorized as under-

1.      Product

·         Consumables

·         Instruments

2.     Technique

·         PCR-based and Microarray Technique

·         Assay-Based Techniques

·         Massively Parallel Sequencing Techniques

·         Other Techniques

3.     Test type

·         Antibody Screening

·         HLA Typing

·         Cross-Matching Tests

·         ABO Blood Tests

·         Antigen Typing

4.     End-users

Hospitals, Blood Banks and Clinical Laboratories.

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/#ulp-c654SbFYO64MsOhu

 

And lastly on the basis of geographical regions, blood grouping reagents market is divided into five major regions- Latin America, North America, Asia Pacific, Europe, the Middle East and Africa. North America holds largest market share due to favorable reimbursement policies for surgeries, and rising incidence of the major blood disorders. Asia-Pacific market is anticipated to show significant growth rate due to rise in incidence and prevalence rate of chronic disorders in Asian countries. Some of the players in the blood grouping reagents market are Grifols, S.A. (Spain), Bio-Rad Laboratories, Inc. (U.S.), Immucor, Inc. (U.S.), Quotient, Ltd. (U.S.), ), Novacyt Group (France), Ortho Clinical Diagnostics, Inc. (U.S.),  BAG Healthcare GmbH (Germany), Day medical SA (Switzerland), Rapid Labs (U.K.), AXO Science (France). And DIAGAST (France). In 2017, Bio-Rad Laboratories, Inc., received U.S. FDA clearance for IH-1000 blood typing instrument to market in the US. In the same year, Immucor, Inc., launched MIA FORA NGS FLEX HLA Typing Assay which provides comprehensive coverage up to 11 HLA genes.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/#ulp-14mlyhjMGhVjZqa3

 

Blood grouping reagents are the vital tools in diagnostic laboratories for blood group serology. Rise number of blood transfusion procedures is anticipated to pose great demand for the blood grouping reagents. In addition to this extended use of blood group reagents for the purpose of research is anticipated to propel the market growth of blood grouping reagents. Every day in U.S., approximately about 36,000 units of RBC, 7,000 units of platelets and 10,000 units of plasma are required and roughly 21 million blood components are transfused every year in U.S.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Cystic Fibrosis (CF) Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 18 Apr 2018 08:34:08 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476567.html http://zend.comunicati.net/comunicati/aziende/editoria/476567.html pbi pbi

Global Cystic Fibrosis (CF) Treatment Market: By Product Type (Pancreatic enzyme supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration (Oral and Inhaled), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Cystic Fibrosis (CF) Treatment Market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Cystic Fibrosis (CF) Treatment Market

Cystic fibrosis is a genetic disorder that causes severe damage to secretory glands of body such as lungs, pancreas, liver and intestines. It is more common in lungs. The disease is progressive with several mutations in the genes, which causes cystic fibrosis. In cystic fibrosis, the abnormal secretions from various secretory glands builds mucus which results in improper working of the organ that is affected. The treatment of cystic fibrosis helps loosening mucus which includes physical therapy. There are various therapeutic products available for the treatment of cystic fibrosis, which include enzymes, antibiotics and others.

 

Market Dynamics: Cystic Fibrosis (CF) Treatment Market

The major factors that are driving cystic fibrosis therapeutics market includes, increasing prevalence of the cystic fibrosis, rising awareness among healthcare fraternity about cystic fibrosis therapy. Advancement in the technology, and better healthcare facilities are also some of the factors influencing the cystic fibrosis therapeutics market. However, the cystic fibrosis therapeutics market growth hindering due to high cost of the treatment, increase in complexity of disease. Moreover, patent expiries from many companies and introduction of generic drugs hold back the growth of global cystic fibrosis market

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Scope: Cystic Fibrosis (CF) Treatment Market

Cystic Fibrosis (CF) treatment market is segmented based on the product type, Route of Administration.

Based on product type, the market is segmented into the following:

·         Pancreatic enzyme supplements

·         Mucolytics

·         Bronchodilators

·         CFTR Modulators

Based on the route of administration, the market is segmented into the following:

·         Oral

·         Inhalation

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-treatment-market/#ulp-c654SbFYO64MsOhu

 

Market Summary: Cystic Fibrosis (CF) Treatment Market

According to CFF’s national patient registry, the median age of the person with cystic fibrosis is currently 33.4 years. Basing on the severity of the disease, cystic fibrosis signs and symptoms vary. The Wide- research on Cystic Fibrosis (CF) resulted in dramatic improvements in the treatment of the disease, which has quadrupled the median life expectancy to 37 years of age in the U.S. In parts of the world where state-of-the-art medical care is not available, life expectancy remains much lower. In Europe, 51.8% were adults with age 18 years or more and 48.2% were less than 18 years old. New therapeutics are currently in development, of which some may provide a functional CFTR protein in patients with some versions of the gene, potentially eliminating many disease complications and allowing people with the disease to live essentially normal lives.

 

Regional Analysis:  Cystic Fibrosis (CF) Treatment Market

Geographically, global Cystic Fibrosis (CF) treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America stands for largest revenue share due to huge affected population. However, the underdiagnoses and lack of country-specific CF patient registries, Asia Pacific region would be forecasted for higher growth of the market. The region that falls next to North America is Europe. According to the European Cystic Fibrosis Society (ECFS), more than 35,500 people were suffering from cystic fibrosis in 2014. The Asian region has lesser prevalence rate. Whereas in East Asian countries like China and Japan the disease is rare. The Middle East and Africa holds the least share in the market owing to the lack of healthcare infrastructure, especially countries in the African region.

 

Competition Assessment: Cystic Fibrosis (CF) Treatment Market

Some of the players in the global Cystic Fibrosis (CF) treatment market include:

·         Vertex Pharmaceuticals Incorporated,

·         Gilead

·         AbbVie Inc

·         Novartis AG.

·         Hoffmann-La Roche Ltd

·         Alaxia, Merck & Co. Inc.

·         AIT (Advanced Inhalation Therapies)

·         ALLERGAN plc

·         AstraZeneca

·         Teva Pharmaceutical Industries Ltd.

·         Alcresta Therapeutics, Inc.

·         Chiesi FarmaceuticiSpA

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-treatment-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Orthopedic Imaging Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 18 Apr 2018 08:05:29 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476564.html http://zend.comunicati.net/comunicati/aziende/editoria/476564.html pbi pbi

Global Orthopedic Imaging Market: By Product Type (X-Ray, Positron Emission Tomography (PET), EOS Imaging Systems, Conventional radiography, Fluoroscopy, Arthrography, Ultrasound, Scintigraphy (Radionuclide Bone Scan), Dual Energy X-Ray Absorptiometry (DEXA or DXA), CT-Scanner, Magnetic Resonance Imaging (MRI)), By Indication (Acute injuries, Chronic Disorders), By Distribution Channel (Hospitals, Radiology Centers, Ambulatory Surgery Center (ASCs), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global orthopedic imaging market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Orthopedic Imaging Market

The growing incidence of the orthopedic disorders lead to the origin of 3D imaging technology. The 3D imaging technology is gaining popularity owing to improved bone examination and proper implantation. The ease of diagnosis of unknown disorders and the bone injuries using the orthopedic imaging technique is gaining more attention among the patient pool. The orthopedic imaging devices help guiding the physicians and the other healthcare workers identify the problem of the patient in a better possible way which helps in early detection of the disease.

 

Market Dynamics: Orthopedic Imaging Market

Orthopedic imaging market is majorly driven by the increase in the incidence of orthopedic disorders and bone injuries such as rheumatoid arthritis, osteoporosis, arthritis, osteoarthritis. The rise in the aging population all over the world is also driving the growth of the orthopedic imaging market. The advancement in the technology help building an improved version of the device which enabling the availability of the device up to date. The medical imaging has revolutionized due to the advent of 3D medical imaging equipment. The awareness about the techniques and tools used for the diagnosis and treatment of orthopedic conditions among the patient pool is expected to drive the orthopedic imaging market. However, the increased investment and lack of skilled professionals are constraining the market revenue growth.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/orthopedic-imaging-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Orthopedic Imaging Market

Orthopedic imaging market is segmented based on the product type, indication, and distribution channel

Based on the product type, the market is segmented into the following:

·         X-Ray

·         Positron Emission Tomography (PET)

·         EOS Imaging Systems

·         Conventional radiography

·         Fluoroscopy

·         Arthrography

·         Ultrasound

·         Scintigraphy (Radionuclide Bone Scan)

·         Dual Energy X-Ray Absorptiometry (DEXA or DXA)

·         CT-Scanner

·         Magnetic Resonance Imaging (MRI)

Based on the indication, the market is segmented into the following:

·         Acute Injuries

o    Trauma cases

o    Sports injuries

·         Chronic Disorders

o    Osteoporosis

o    Osteoarthritis

o    Prolapsed Disc

o    Degenerative Joint Diseases

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Radiology Centers

·         Ambulatory Surgery Center (ASCs)

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/orthopedic-imaging-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Orthopedic Imaging Market

Geographically, global orthopedic imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America orthopedic imaging market is growth driven by increase in the aging population in the region. According to the Centers for Disease Control and Prevention (CDC), in the US 54.4 million adults had arthritis in 2017 and the numbers are expected grow considerably over the forecasted period. Due to the availability of key vendors and advanced infrastructure the market in this region is witnessing the robust growth. The European region and the emerging countries of Asia Pacific region are showing higher growth rate due to the rising adoption of imaging technology. The factors such as boosting product approvals and the increased healthcare expenditure are driving the growth of orthopedic imaging market in these regions.

 

Competition Assessment: Orthopedic Imaging Market

Some of the players in the global orthopedic imaging market include:

·         Philips Healthcare (Netherlands )

·         Siemens Healthineers (Germany)

·         Toshiba Medical Systems (Japan)

·         GE Healthcare (U.S)

·         Hitachi (Japan)

·         Koninklijke Philips (Netherlands)

·         Siemens (Germany)

·         Ziehm Imaging (Germany)

 

Notable Market Developments: Orthopedic Imaging Market

·         In June 2017, Siemens Healthineers launches Symbia Intevo Bold SPECT/CT scanner.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/orthopedic-imaging-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/orthopedic-imaging-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Organic Foods and Beverages Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 18 Apr 2018 07:49:14 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476562.html http://zend.comunicati.net/comunicati/aziende/editoria/476562.html pbi pbi

Global Organic Foods and Beverages Market: By Product Type (organic food, organic beverage), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global organic foods and beverages market projected to be valued at USD 295.1 Bn in 2024 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Organic Foods and Beverages Market

Organic foods are produced by organic farming methods. The organic foods are not processed using industrial solvents or the synthetic food additives. They also regulate the use of certain fertilizers and pesticides. The fruits and vegetables are dominating the global organic food market. The demand for the organic beverages is also expected to grow over the forecasted period. The products such as soymilk, rice etc. are exhibiting larger share in the global organic beverage market. The organic food and beverage market is estimated to grow at significant rate over the forecasted period.

 

Market Dynamics: Organic Foods and Beverages Market

Increasing health consciousness is the major factor influencing the growth of the organic foods and beverages market. The organic foods offer the higher health benefits, which is gaining popularity all over the globe. The rising demand for the organic wine driving the growth of the organic foods and beverages market. The wine manufacturers are being encouraged to adopt the organic winemaking owing to increased demand for the organic wine. The rising awareness among the people regarding the organic products and the advantages of the organic food is adding fuel to the market. The rising count of the health hazardous diseases owing to inorganic food is likely to enhance the growth of the organic foods and beverages market. However, the low-shelf life and higher price of the organic food is hampering the growth of the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/organic-foods-and-beverages-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Organic Foods and Beverages Market

Organic foods and beverages market is segmented based on the product type.

Based on the product type, the market is segmented into the following:

·         Organic Foods

o    Fruits & Vegetables

o    Dairy Products

o    Meat, Fish & Poultry

o    Frozen & processed Food

o    Others

·         Organic Beverage

o    Non-dairy beverage

o    Coffee & Tea

o    Beer & Wine

o    Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/organic-foods-and-beverages-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Organic Foods and Beverages Market

Geographically, global organic foods and beverages market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America organic foods and beverages market is dominant when compared with that of the other regional markets. The growing awareness among the people regarding the beneficial effects of the organic foods driving the market in the region. Followed by the North America are the regions of Europe and Asia-Pacific. The Asia Pacific is expected show a rapid growth over the forecasted period. The government and the non-profitable organizations are encouraging the farmers to adopt the organic techniques in their farming which would help emerge the organic foods and beverages market in the region.

 

Competition Assessment: Organic Foods and Beverages Market

Some of the players in the global organic foods and beverages market include:

·         Amys Kitchen Inc.(U.S)

·         WhiteWave Foods Company (U.S)

·         Hain Celestial (U.S)

·         General Mills Inc. (U.S)

·         Starbucks Corporation (U.S)

·         Whole Foods Market Inc. (U.S)

·         Kroger Co. (U.S)

·         Dole Food Company (U.S)

·         Nestlé (Switzerland)

 

Notable Market Developments: Organic Foods and Beverages Market

·         In January 2018, Kroger Co. announced the expansion of its Simple Truth® brand and launch of its largest-ever customer sales promotion, featuring savings on thousands of Simple Truth and Simple Truth Organic items.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/organic-foods-and-beverages-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/organic-foods-and-beverages-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Organ and Tissue Transplantation Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 18 Apr 2018 07:29:41 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476559.html http://zend.comunicati.net/comunicati/aziende/editoria/476559.html pbi pbi

Global Organ and Tissue Transplantation Market: By Product (Immunosuppressants, Preservation Solutions, and Tissue Products) By Application (Organ Transplantation, Tissue Transplantation), By End User (Hospitals, Transplantation Centers, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global organ and tissue transplantation market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Organ and Tissue Transplantation Market

Organ and tissue transplantation saves many lives and restores the essential functions of the body. The organ transplantation is the medical procedure in which the organ is removed from one body and is placed in the recipient’s body. The organs which can be transplanted include kidneys, heart, intestine, thymus, liver, lings and pancreas. The tissues include skin, cornea, heart valve, tendons and bones. The organ failure generally occurs owing to several conditions such as poising, serious trauma, drug abuse, and so on. The organ transplantation is the final stage of the treatment in organ failure.

 

Market Dynamics: Organ and Tissue Transplantation Market

Increase in the prevalence of chronic diseases and rising organ and tissue transplantation owing to organ damage or impairment is the key factor driving the growth of the organ and tissue transplantation market. The improving technology for organ and tissue transportation and transplantation is adding fuel for the growth of the market. The increasing investments in the research and development is providing opportunity for the growth of the organ and tissue transplantation market. However, the increasing incidence of the organ failures post-surgery is hampering the growth of the market. The limited number of donors is also and high cost involved in the treatment is expected to restrain the growth of the organ and tissue transplantation market. Lack of awareness regarding the organ donation is likely to constrain the growth of the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/organ-and-tissue-transplantation-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Organ and Tissue Transplantation Market

Organ and tissue transplantation market is segmented based on the application and distribution channel

Based on the product type, the market is segmented into the following:

·         Immunosuppressants

·         Preservation Solutions

·         Tissue Products

Based on the application, the market is segmented into the following:

·         Organ Transplantation

o    Heart

o    Lungs

o    Liver

o    Kidney

o    Intestine/Small Bowel

o    Pancreas

·         Tissue Transplantation

o    Skin Transplantation

o    Cellular Transplantation

o    Cornea

o    Vascular Transplantation

o    Bone Graft Transplantation

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Transplantation Centers

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/organ-and-tissue-transplantation-market/#ulp-c654SbFYO64MsOhu

 

 

Regional Analysis:  Organ and Tissue Transplantation Market

Geographically, global organ and tissue transplantation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America organ and tissue transplantation market growth is driven advanced technology. The increasing prevalence of the chronic diseases such as diabetes may cause renal failure which require organ transplantation. As per the National Kidney Foundation, there were approximately 122,737 patients waiting for the transplantation of their organs in the U.S. Following the North America, are the regions of Europe and Asia Pacific. The Asia Pacific expected to grow at significant rate over the forecast period owing to its developing economy and huge patient pool.

 

Competition Assessment: Organ and Tissue Transplantation Market

Some of the players in the global organ and tissue transplantation market include:

·         Hoffmann-La Roche Ltd. (Switzerland)

·         Novartis International AG (Switzerland)

·         OrganOX Limited (UK)

·         Terumo Medical Corporation (US)

·         Transonic (US)

·         Bio Med Pvt. Ltd. (US)

·         Transplant Biomedical (UK)

·         GlaxoSmithKline Plc. (UK)

·         Accord Healthcare GmbH (Spain)

·         Sanofi (France)

·         Pfizer, Inc. (US)

 

Notable Market Developments: Organ and Tissue Transplantation Market

·         In April 2017, Sanofi has received FDA Approval of Thymoglobulin for the Prevention of Acute Kidney Transplant Rejection

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/organ-and-tissue-transplantation-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/organ-and-tissue-transplantation-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Markets for Media, Sera and Reagents in Biotechnology: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 18 Apr 2018 07:10:47 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476557.html http://zend.comunicati.net/comunicati/aziende/editoria/476557.html pbi pbi

Global Markets for Media, Sera and Reagents in Biotechnology:  Media Market (Serum-free media, Chemically defined media, Animal-free media), Sera Market (Fetal bovine serum, Newborn Calf, Others), By Reagents Market (Cell Dissociation Reagents, Buffers and Salt Solution, Cytokines and Growth Factors, Others), and Geography -Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global markets for media, sera and reagents in biotechnology was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Markets for Media, Sera and Reagents in Biotechnology

Cell culture is the technique where in which the cells are grown in the created conditions which could be controlled. The conditions, at which the cells are grown, differ from cell to cell basing on their type. Since the cells are not grown under the natural conditions, they need proper reagents which could provide essential nutrients for the cell to grow in the artificial conditions. There are various types of media, sera and reagents that are available for the cell culture.

 

Market Dynamics: Markets for Media, Sera and Reagents in Biotechnology

Increase in the development of biopharmaceuticals is creating a major impact on the growth of the markets for media, sera and reagents in biotechnology. The increase in the prevelance of the chronic diseases and growing investments in the research and development in the biotechnology is also enriching the growth of the market. The various developments owing to the r-DNA technology is enhancing the growth of the market. However, the incresing initial investments and strict government regulations are likely to hindr the growth of the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/markets-for-media-sera-and-reagents-in-biotechnology/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Markets for Media, Sera and Reagents in Biotechnology

Markets for media, sera and reagents in biotechnology is segmented based on the media market, sera market and reagents market

The media market is segmented into the following:

·         Serum-free media

·         Chemically defined media

·         Animal-free media

The sera market is segmented into the following:

·         Fetal bovine serum

·         Newborn Calf

·         Others

The reagents market is segmented into the following:

·         Cell Dissociation Reagents

·         Buffers and Salt Solution

·         Cytokines and Growth Factors

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/markets-for-media-sera-and-reagents-in-biotechnology/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Markets for Media, Sera and Reagents in Biotechnology

Geographically, global markets for media, sera and reagents in biotechnology are segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market for media, sera and reagents in biotechnology are growing due to advances in biotechnology. The advancements in the technology is adding scope for the market to expand in various geographical areas. The increase in funding for the research and development activities is playing a vital role in the growth of the market in this region. The well-built healthcare infrastructure and the support from the government is helping in the growth of the market.

 

Competition Assessment: Markets for Media, Sera and Reagents in Biotechnology

Some of the players in the global Markets for Media, Sera and Reagents in Biotechnology include:

·         Merck KGaA (Germany)

·         Lonza AG (Switzerland)

·         Hi-media Laboratories (India)

·         PAN biotech (Germany)

·         Sigma Aldrich (US)

·         Thermofisher Scientific (US)

·         General electric company (US)

·         Biowest (France)

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/markets-for-media-sera-and-reagents-in-biotechnology/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/markets-for-media-sera-and-reagents-in-biotechnology/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Hyaluronic Acid Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Fri, 13 Apr 2018 10:05:45 +0200 http://zend.comunicati.net/comunicati/arte/musica/rock/476153.html http://zend.comunicati.net/comunicati/arte/musica/rock/476153.html pbi pbi

Global Hyaluronic Acid Market: By Product (Single-injection, Three-injection, Five-injection), By Route of administration (Oral, Parenteral), By Application (Ophthalmic surgery, Osteoarthritis, Dermal fillers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

The global hyaluronic acid market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Hyaluronic Acid Market

Hyaluronic acid is a substance that is naturally present in the human body. The higher concentration of the hyaluronic acid is present in the fluids in the eyes and joints. The hyaluronic acid is used in various treatments such as joint disorders, including osteoarthritis. The FDA has approved the use of hyaluronic acid during certain eye surgeries such as cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. Hyaluronic acid is also used in cosmetic treatments.

 

Market Dynamics: Hyaluronic Acid Market

The increasing geriatric population considerable increases in prevalence of diseases such ulcers, eye diseases and osteoarthritis is likely to drive the growth of the hyaluronic acid market. The growing use of the hyaluronic acid for the treatments such as dry eyes, mouth sores and increasing popularity of the non-surgical procedures with cost-effectiveness expected to drive the growth of the hyaluronic acid market. The non-surgical procedures in aesthetics include botulinum toxin, dermal fillers, laser treatments, chemical peels, and microdermabrasion. The hyaluronic acid injection heals damage caused by scars, wounds, lines. The rising demand for the hyaluronic acid for cosmetic treatments and usage of the hyaluronic acid surfaces in various cardiovascular implants, such as stents and vascular grafts is also driving the growth of the hyaluronic acid market. However, the higher cost of the hyaluronic acid products is likely to hamper the growth of the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/hyaluronic-acid-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Hyaluronic Acid Market

Hyaluronic acid market is segmented based on the route of administration, application, and distribution channel

Based on the application, the market is segmented into the following:

·         Ophthalmic surgery

·         Osteoarthritis

·         Dermal fillers

·         Vesicoureteral Reflux (VUR)

Based on the route of administration, the market is segmented into the following:

·         Oral

·         Parenteral

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/hyaluronic-acid-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Hyaluronic Acid Market

Geographically, global hyaluronic acid market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is the dominant market in global hyaluronic acid market. Owing to the rising geriatric population and growing awareness about the cost-effective non-surgical procedures is driving the aesthetics market in the region. The Asia Pacific is expected to be the fastest growing region during the forecast period. The increasing geriatric population in the countries of China and Japan provides a large patient pool for the hyaluronic acid treatment in various segments such as osteoarthritis and age related skin issues. Increasing awareness about applications of hyaluronic acid products and its efficacy is also adding fuel to the hyaluronic acid market in this region.

 

Competition Assessment: Hyaluronic Acid Market

Some of the players in the global hyaluronic acid market include:

·         Alcon, Inc (U.S)

·         Allergan, Inc. (Ireland)

·         Ferring Pharmaceuticals, Inc. (Switzerland)

·         Fidia Farmaceutici SpA (Italy)

·         GALDERMA S.A. (Switzerland)

·         Hyaltech Ltd (UK)

·         Anika Therapeutics, Inc (U.S)

·         LifeCore Biomedical LLC (U.S)

·         Salix Pharmaceuticals, Inc. (U.S)

·         Smith & Nephew plc (UK)

 

Notable Market Developments: Hyaluronic Acid Market

·         In March 2018, Galderma launched the new Restylane range in Saudi Arabia.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/hyaluronic-acid-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/hyaluronic-acid-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Germany Facial Aesthetics Market: Market Estimation, Dynamics, Segment Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Fri, 13 Apr 2018 09:56:23 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476152.html http://zend.comunicati.net/comunicati/aziende/editoria/476152.html pbi pbi

Germany facial aesthetics market was valued at US $ XX Mn in 2016 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Germany Facial Aesthetics Market

The Facial Aesthetics is the term used to describe the various range of the non-surgical treatments that offers temporarily soften expression lines, and define certain facial features and counters. The natural aging process, lifestyle and the environment contribute to these unwanted facial wrinkles, lines, and uneven skin tones. With the careful use of wrinkle relaxation injections or injectable fillers, the natural beauty can be enhanced. Facial aesthetics market is gaining popularity all over the globe. In the European region, Germany is one of the major country leading the facial aesthetics market.

 

Market Dynamics: Germany Facial Aesthetics Market

Increasing beauty conscious and the growing trends in the cosmetic industry are anticipating people to adopt the aesthetic treatment. The developing technology with the new products in the market driving the growth of the facial aesthetic market in Germany. The growing urban population and the increasing advancements in the non-invasive procedures are enriching the growth of the Germany facial aesthetic market. The improving count of the cosmetic professionals is also adding scope for the expansion of the cosmetic clinics which is enhancing the growth of the Germany facial aesthetics market. However, the high cost involved in the aesthetic procedures are likely to hamper the growth of the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/germany-facial-aesthetics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Germany Facial Aesthetics Market

Germany facial aesthetics market is segmented based on the product type, technology, disease indication, and distribution channel

Based on the technology, the market is segmented into the following:

·         Laser Based Technology

·         Energy Based Technology

·         Others

Based on the products, the market is segmented into the following:

·         Aesthetic Implants

o    Chin Implants

o    Jaw Implants

o    Others

·         Aesthetic Lasers and Energy Devices

o    Laser Resurfacing Devices

o    Body Contouring Devices

·         Aesthetic Products

o    Dermal Fillers

o    Botulinum Toxins

o    Others

Based on the distribution channel, the market is segmented into the following:

·         Dermatology Clinics

·         Medical Spa’s

·         Others

 

 

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/germany-facial-aesthetics-market/#ulp-c654SbFYO64MsOhu

 

Competition Assessment: Germany Facial Aesthetics Market

Some of the players in the global Germany facial aesthetics market include:

·         ALLERGAN

·         SYNERON MEDICAL

·         NOBEL BIOCARE

·         MENTOR

·         Merz Pharma

·         Valeant Pharmaceuticals Inc

·         Adoderm GmbH

·         Teoxane

 

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/germany-facial-aesthetics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Germany Facial Aesthetics Market

·         In April 2017, Allergan successfully completed ZELTIQ aesthetics acquisition

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies and regulatory framework

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/germany-facial-aesthetics-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Germany Dermal Fillers Market: Market Estimation, Dynamics, Segment Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Fri, 13 Apr 2018 09:46:42 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476149.html http://zend.comunicati.net/comunicati/aziende/editoria/476149.html pbi pbi

Germany dermal fillers market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Germany Dermal Fillers Market

Dermal fillers or the soft tissue fillers are the medical devices also known as the injectable implants. The dermal fillers are approved by the Food and Drug Administration (FDA) for the use of various cosmetic treatments. These dermal fillers help diminish facial lines and restore the natural beauty of the face. With the growing age, the face naturally loses the subcutaneous fat. The facial skin also stretches, so the loss of facial volume becomes more apparent. Also, there are various factors affecting the skin which includes heredity and sun exposure. Dermal fillers are very advantageous to the people with early signs of aging.

 

Market Dynamics: Germany Dermal Fillers Market

Increase in a number of aging population in Germany and changing lifestyle is attracting people towards the modern aesthetic trends, which are driving the Germany dermal fillers market. The growing beauty conscious is driving the people to approach the new cosmetic procedures. The non-invasive procedures are also gaining more popularity and growing demand for the facial aesthetics is increasing the acceptance of tissue fillers or the dermal fillers in Germany which is likely to drive the dermal fillers market in Germany. However, the high cost associated with the dermal filling treatment is likely to hamper the growth of the dermal fillers market in Germany.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/germany-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Germany Dermal Fillers Market

Germany dermal fillers market is segmented based on the product type, ingredient type and distribution channel

On basis of product type, the Germany dermal fillers market is segmented into

·         Absorbable Dermal Fillers

·         Non-Absorbable Dermal Fillers

On basis of the ingredient, the Germany dermal fillers market is segmented into

·         Hyaluronic Acid (HLA)

·         Poly-L-Lactic Acid (PLA)

·         Calcium Hydroxylapatite (CaH)

·         Polymethylmethacrylate (PMMA)

·         Collagen

·         Others

 

On basis of a distribution channel, the Germany dermal fillers market is segmented into

·         Retail Pharmacies

·         Beauty Clinics

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/germany-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

 

 

Competition Assessment: Germany Dermal Fillers Market

Some of the players in the Germany dermal fillers market include:

·         Merz Pharma

·         Allergan

·         GALDERMA

·         Integra Lifesciences

·         Sinclair Pharma

·         Teoxane laboratories

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/germany-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies and regulatory framework

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/germany-dermal-fillers-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
France Facial Aesthetics Market: Market Estimation, Dynamics, Segment Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Fri, 13 Apr 2018 09:35:43 +0200 http://zend.comunicati.net/comunicati/aziende/editoria/476148.html http://zend.comunicati.net/comunicati/aziende/editoria/476148.html pbi pbi

France Facial Aesthetics Market: By Technology (Laser Based Technology, Energy Based Technology), By Products (Aesthetic Lasers and Energy Devices, Aesthetic Implants), By End User (Dermatology Clinics, Medical Spa’s, Others),  and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

France facial aesthetics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: France Facial Aesthetics Market

The medical aesthetics involve high-technology care which is a cross of healthcare and beauty services. The aesthetic procedure is a significant cosmetic enhancement. The facial aesthetics are gaining popularity owing to its beneficial results. The facial expressions such as smiling, laughing cause lines and creases to develop on the face over time, mainly as the skin loses its natural elasticity. These lines are usually associated with ageing. The facial aesthetics are used to soften the expression lines and define facial contours. The facial aesthetics market is expected to grow in the region of France in the forecasted period.